 Ryan O'Connell
Concepts (100)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Antibodies, Bispecific | 1 | 2024 | 68 | 0.770 |
Why?
| | Transgender Persons | 2 | 2025 | 210 | 0.690 |
Why?
| | Carcinoma, Renal Cell | 1 | 2024 | 230 | 0.690 |
Why?
| | Family Planning Services | 1 | 2022 | 93 | 0.670 |
Why?
| | Kidney Neoplasms | 1 | 2024 | 415 | 0.600 |
Why?
| | Myocardium | 4 | 2020 | 935 | 0.490 |
Why?
| | T-Lymphocytes | 1 | 2024 | 1998 | 0.460 |
Why?
| | Ion Transport | 1 | 2015 | 62 | 0.450 |
Why?
| | Heart Atria | 2 | 2015 | 141 | 0.440 |
Why?
| | Fatty Acids, Nonesterified | 1 | 2015 | 154 | 0.430 |
Why?
| | Opioid-Related Disorders | 1 | 2022 | 605 | 0.400 |
Why?
| | Physicians | 1 | 2021 | 956 | 0.360 |
Why?
| | Contraception | 2 | 2025 | 170 | 0.350 |
Why?
| | Internship and Residency | 1 | 2021 | 1269 | 0.310 |
Why?
| | Medroxyprogesterone Acetate | 1 | 2025 | 33 | 0.230 |
Why?
| | Immunotherapy | 3 | 2024 | 668 | 0.210 |
Why?
| | Carbonic Anhydrase IX | 1 | 2024 | 4 | 0.210 |
Why?
| | Contraceptive Agents, Female | 1 | 2025 | 80 | 0.210 |
Why?
| | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2023 | 26 | 0.200 |
Why?
| | Receptors, FSH | 1 | 2022 | 9 | 0.190 |
Why?
| | Sex Education | 1 | 2022 | 34 | 0.180 |
Why?
| | Pregnancy, Unplanned | 1 | 2022 | 48 | 0.180 |
Why?
| | Potassium Channels, Inwardly Rectifying | 2 | 2014 | 46 | 0.170 |
Why?
| | Hematologic Neoplasms | 1 | 2023 | 168 | 0.170 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2024 | 936 | 0.160 |
Why?
| | Discs Large Homolog 1 Protein | 1 | 2020 | 3 | 0.160 |
Why?
| | Gender Identity | 1 | 2021 | 129 | 0.150 |
Why?
| | Action Potentials | 2 | 2014 | 502 | 0.150 |
Why?
| | Patient Acceptance of Health Care | 1 | 2025 | 883 | 0.140 |
Why?
| | Sheep | 3 | 2015 | 876 | 0.130 |
Why?
| | Arrhythmias, Cardiac | 1 | 2020 | 356 | 0.130 |
Why?
| | Atrial Fibrillation | 2 | 2014 | 558 | 0.120 |
Why?
| | Ovarian Neoplasms | 1 | 2022 | 596 | 0.120 |
Why?
| | Cell Line, Tumor | 1 | 2024 | 3551 | 0.120 |
Why?
| | Heart | 1 | 2020 | 626 | 0.120 |
Why?
| | Electrophysiology | 1 | 2015 | 218 | 0.110 |
Why?
| | Immunoblotting | 1 | 2015 | 295 | 0.110 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 2015 | 331 | 0.110 |
Why?
| | Animals | 8 | 2024 | 38101 | 0.100 |
Why?
| | Sinoatrial Node | 1 | 2014 | 27 | 0.100 |
Why?
| | Sodium Channels | 1 | 2014 | 63 | 0.100 |
Why?
| | Mice | 5 | 2024 | 18355 | 0.100 |
Why?
| | Calcium Channels, L-Type | 1 | 2014 | 117 | 0.090 |
Why?
| | Kv1.5 Potassium Channel | 1 | 2012 | 2 | 0.090 |
Why?
| | Sulfenic Acids | 1 | 2012 | 6 | 0.090 |
Why?
| | Female | 5 | 2025 | 79045 | 0.090 |
Why?
| | Purkinje Cells | 1 | 2012 | 65 | 0.090 |
Why?
| | Cells, Cultured | 2 | 2015 | 4151 | 0.080 |
Why?
| | Myocytes, Cardiac | 4 | 2020 | 546 | 0.080 |
Why?
| | Humans | 9 | 2025 | 145783 | 0.080 |
Why?
| | Male | 4 | 2025 | 73010 | 0.080 |
Why?
| | Heart Rate | 1 | 2014 | 856 | 0.080 |
Why?
| | Pregnancy | 1 | 2022 | 7216 | 0.070 |
Why?
| | Ion Channel Gating | 1 | 2009 | 94 | 0.070 |
Why?
| | Surveys and Questionnaires | 1 | 2021 | 6085 | 0.070 |
Why?
| | Heart Ventricles | 1 | 2012 | 756 | 0.060 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2009 | 426 | 0.060 |
Why?
| | Disease Progression | 1 | 2014 | 2865 | 0.060 |
Why?
| | Membrane Proteins | 1 | 2009 | 1166 | 0.050 |
Why?
| | Focus Groups | 1 | 2025 | 572 | 0.050 |
Why?
| | Gene Editing | 1 | 2023 | 89 | 0.050 |
Why?
| | Patch-Clamp Techniques | 2 | 2014 | 289 | 0.050 |
Why?
| | Counseling | 1 | 2025 | 401 | 0.040 |
Why?
| | Adaptive Immunity | 1 | 2022 | 167 | 0.040 |
Why?
| | Epitopes | 1 | 2023 | 473 | 0.040 |
Why?
| | Adult | 1 | 2022 | 40881 | 0.040 |
Why?
| | Tumor Microenvironment | 1 | 2022 | 735 | 0.030 |
Why?
| | Qualitative Research | 1 | 2025 | 1683 | 0.030 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2022 | 1150 | 0.030 |
Why?
| | Cell Line | 2 | 2012 | 2823 | 0.030 |
Why?
| | Antibodies, Monoclonal | 1 | 2022 | 1505 | 0.030 |
Why?
| | Hypertrophy | 1 | 2014 | 128 | 0.020 |
Why?
| | Electrophysiologic Techniques, Cardiac | 1 | 2014 | 82 | 0.020 |
Why?
| | Cardiac Pacing, Artificial | 1 | 2014 | 84 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2020 | 3130 | 0.020 |
Why?
| | Rats | 2 | 2012 | 5585 | 0.020 |
Why?
| | Potassium Channels | 1 | 2012 | 148 | 0.020 |
Why?
| | Sodium | 1 | 2012 | 198 | 0.020 |
Why?
| | Models, Animal | 1 | 2012 | 392 | 0.020 |
Why?
| | Cytoplasmic Vesicles | 1 | 2009 | 14 | 0.020 |
Why?
| | Reactive Oxygen Species | 1 | 2012 | 611 | 0.020 |
Why?
| | Guinea Pigs | 1 | 2009 | 159 | 0.020 |
Why?
| | Membrane Potentials | 1 | 2009 | 278 | 0.020 |
Why?
| | Oxidation-Reduction | 1 | 2012 | 1069 | 0.020 |
Why?
| | Young Adult | 1 | 2025 | 14254 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 2012 | 2131 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 2012 | 2883 | 0.020 |
Why?
| | Protein Transport | 1 | 2009 | 442 | 0.020 |
Why?
| | Transfection | 1 | 2009 | 927 | 0.020 |
Why?
| | Protein Structure, Tertiary | 1 | 2009 | 855 | 0.020 |
Why?
| | Calcium | 1 | 2012 | 1191 | 0.010 |
Why?
| | Protein Conformation | 1 | 2009 | 938 | 0.010 |
Why?
| | Binding Sites | 1 | 2009 | 1311 | 0.010 |
Why?
| | Adolescent | 1 | 2025 | 22577 | 0.010 |
Why?
| | Cell Membrane | 1 | 2009 | 709 | 0.010 |
Why?
| | Oxidative Stress | 1 | 2012 | 1360 | 0.010 |
Why?
| | Case-Control Studies | 1 | 2012 | 3634 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2014 | 4568 | 0.010 |
Why?
| | Time Factors | 1 | 2014 | 7134 | 0.010 |
Why?
| | Signal Transduction | 1 | 2012 | 5224 | 0.010 |
Why?
|
|
O'Connell's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|